Today3 [Compatibility Mode]

Embed Size (px)

Citation preview

  • 8/3/2019 Today3 [Compatibility Mode]

    1/62

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    2/62

    Prof in Forensic Medicine and Clinical Toxicology

    Department

    AND

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    3/62

  • 8/3/2019 Today3 [Compatibility Mode]

    4/62

    OUTLINE OF LECTURE

    Definitions and classification of poisons

    Phases of poisoning

    Factors affecting the severity of poisoning

    Diagnosis

    Treatment

  • 8/3/2019 Today3 [Compatibility Mode]

    5/62

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    6/62

    Enhancement of eliminationEnhancement of elimination

    Lung (Oxygen + CO2)

    Intestine (purgatives)

    Lung (Oxygen + CO2)

    Intestine (purgatives)

    e repeate oses o . .

    Kidney (Diuresis + dialysis)

    e repeate oses o . .

    Kidney (Diuresis + dialysis)

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    7/62

    dose activated charcoal-Repeat

    Dose: 20-30 or 0.5-1 k ever 4 hours are

    given orally or via gastric tube.

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    8/62

    dose activated charcoal-RepeatReduces the blood concentration of a toxin by

    either: Interrupting enterohepatic or enteroenteric circulation

    (e.g. morphine, dapsone, digitoxin, carbamazepines, and

    TCA).

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    9/62

    dose activated charcoal-RepeatReduces the blood concentration of a toxin by

    either:

    Allow toxin diffusion passively from the

    (gasterointestinal dialysis) as theophylline.

    Adsorption ofdrugs still present in the gut

    as drugs forming concretions (salicylate),SR preparations (theophylline), and drugs

    slowing the GIT motility (anticholinergics).

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    10/62

    dose activated charcoal-RepeatIndications:

    Shorten the half-life of:

    Carbamazepine

    DigitoxinPhenytoin

    Phenobarbital

    Salicylate

    Theophylline.

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    11/62

    dose activated charcoal-RepeatAdverse effects:

    Serious fluid and electrolyte disturbance

    secondary to large-volume diarrhea, especially

    -

    used.

    It should not be used in patients with ileus or

    obstruction.

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    12/62

    DiuresisDiuresis

    Fluid

    Osmotic

    Fluid

    Osmotic

    orce a a ne + ac corce a a ne + ac c

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    13/62

    DiuresisDiuresis

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    14/62

    Indications of forced diuresis

    The poison excreted mainly in urine.

    Low protein bound.

    Weak acid or weak alkali.

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    15/62

    Contraindications of forced diuresis

    The poison not excreted in urine in active

    form.

    Shock.

    Heart ai ure. Renal dysfunction.

    The poison produces pulmonary edema.

    Lack facilities to monitor plasma electrolytes

    level.

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    16/62

    Alkaline dieresis Salicylate, lithium, meprobamate and

    phenobarbital are weak acids. By promoting an alkaline urine (PH 7-8),

    Drugs wi ecome more ionize in t e istatubular lumen, which will slow tubular re-

    absorption and allow a larger fraction of the

    drug to be excreted without being reabsorbedback into the body.

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    17/62

    Alkaline dieresis Give sodium bicarbonate 1-2 mEq/kg in 1L

    saline / hour every 3-4 hours followed byinfusion of 500 cc dextrose 5% and saline

    .

    Correct hypokalemia by adding 10 20 mEq/L

    IV.

    It enhances elimination of polar drugs by iontrapping.

    Requires normal renal.14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    18/62

    Alkaline dieresis

    Maintain: Urine pH at 7-8.

    - .

    Blood pH at 7.35-7.45.

    Electrolytes and correct any abnormality (e.g.

    hypokalemia).

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    19/62

    Alkaline dieresis

    Indications: Salicylate overdose.

    .

    Lithium overdose.

    Poisons producing hemolysis or

    rhabdomyolysis.

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    20/62

    Alkaline dieresisAdverse effects:

    Fluid overload. Acid-base abnormalities (alkalosis).

    ectro yte a norma t es e.g. ypo a em a,hypernatremia).

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    21/62

    DialysisDialysis

    The poison moves against concentration

    gradients across semipermeable membranes

    t roug us ng: Physiologic membrane (peritoneum)

    Artificial membrane (hemodialysis).

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    22/62

    DialysisDialysis

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    23/62

    DialysisDialysis

    HemodialysisHemodialysis

    hemoperfusion

    Peritoneal

    hemoperfusion

    Peritoneal

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    24/62

    HaemodialysisHaemodialysis

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    25/62

    HaemodialysisHaemodialysis

    Drugs and toxins flow passively across the

    semipermeable membrane down aconcentration gradient into a dialysate

    .

    electrolyte abnormalities can be corrected

    concurrently.

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    26/62

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    27/62

    Indications Hemodialysis is preferred for salicylate,

    phenobarbital, ethanol, and methanol whichhave the following characters:

    .

    Low lipid solubility (high water solubility).

    Low volume of distribution.

    Low plasma protein binding.

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    28/62

    Adverse effects Hemorrhage (secondary to anticoagulation).

    Hypotension.

    Hepatitis, AIDS and other nosocomial

    in ections. Thrombosis at the site of venous access.

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    29/62

    HaemodialysisHaemodialysis

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    30/62

    Peritoneal DialysisPeritoneal Dialysis

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    31/62

    Peritoneal DialysisPeritoneal Dialysis

    Dialysate fluid is infused into the

    peritoneal cavity through a transcutaneous

    catheter and drained off, and the procedure is

    repeate w t res a ysate.The gut wall and peritoneal lining serve as

    the semipermeable membrane.

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    32/62

    Peritoneal DialysisPeritoneal Dialysis

    Indications: The same as hemodialysis.

    NB: Peritoneal dial sis is easier to er orm than

    hemodialysis or hemoperfusion, but it is onlyabout 10 15% as effective.

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    33/62

    Peritoneal DialysisPeritoneal Dialysis

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    34/62

    HaemoperfusionHaemoperfusion

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    35/62

    HaemoperfusionHaemoperfusion

    During hemoperfusion, blood is drived to pass

    through a cartridge coated with activatedcharcoal to which toxic agents in the blood

    .

    to the patient.

    Anticoagulation with heparin is necessary.

    Calcium & glucose monitoring should be doneas they may be adsorbed to charcoal.

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    36/62

    HaemoperfusionHaemoperfusion

    Indications:

    Not limited by protein binding, molecularweight or water solubility.

    It is the referred method for theo h lline

    paraquate, carbamazepine, phenytoin,phenobarbitone which have the following

    characters:

    Adsorbed by activated charcoal.

    Low volume of distribution.

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    37/62

    HaemoperfusionHaemoperfusion

    Adverse effects: Similar to those of

    hemodialysis in addition to the following:

    Thrombocytopenia.

    Leucopenia.

    Hypoglycemia. Hypocalcemia.

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    38/62

    Hemoperfusion

    Blood

    ARTERY

    or

    VEINVEIN

    Return

    Uses hemodialysis machine - but runs blood directlythrough a charcoal- or sorbent-containing filter

    rom

    patientto

    patient

  • 8/3/2019 Today3 [Compatibility Mode]

    39/62

    Physiological antidotesNeutralise poison

    Physiological antidotesNeutralise poison

    Mechanism:

    Antagonism

    em ca n ng Immunological binding

    Competition of enzyme

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    40/62

    Antidotes (ANTAGONISING THE EFFECTS OF THE POISON

    Antidote PoisonN-acetylcysteine acetaminophenatro ine or ano hos hate

    Ca gluconate or Ca chloride Calcium channel blockersCyanide kit cyanide

    Deferoxamine Iron

    Fab digoxin DigoxinDimercaprol (BAL) Arsenic, mercury, lead

  • 8/3/2019 Today3 [Compatibility Mode]

    41/62

    AntidotesAntidote poison

    ethanol MeOH, et glycolflumazenil Benzodiazepine

    Fomepizole MeOH

    glucagon -blocker, CCB

    Methylene blue methemoglobin

    naloxone opioidsphysostigmine anticholinergic

    pralidoxime organophosphate

    pyridoxine isoniazid

    Sodium bicarbonate TCA, cocaine, salicylates

  • 8/3/2019 Today3 [Compatibility Mode]

    42/62

    Supportive treatmentSupportive treatment

    Coma

    Acid base disorders

    Dehydration

    Rhabdomyolysis

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    43/62

    ComaComa

    CirculationRespirationReflexes

    response

    Pain

    response

    Conscious

    level

    Stage

    NormalNormalIntactArousableA sleep0

    NormalNormalIntactWithdrawsComatoseI

    NormalNormalIntactNoneComatoseII

    NormalNormalAbsentNoneComatoseIII

    ShockCyanosisAbsentNoneComatoseIV

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    44/62

    Causes of ComaCauses of Coma

    General CNS depressants: Barbiturates

    Benzodiazepines, alcohols. - Cellular hypoxia: Carbon monoxide, Cyanide,

    , .

    - Sympatholytic agents: Clonidine,

    Tetracycline, Methyldopa, Opiates.

    - Others: Hypoglycemic agents, Disulfiram,Salycylates.

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    45/62

    Treatment of ComaTreatment of Coma

    As acute poisoning:

    Give:

    Dextrose (50%, 50ml IV) to correct hypoglycemia.

    Thiamine (100 mg IV), to correct suspected

    vitamin deficiencies.

    Naloxone (0.4 mg IV) to correct respiratory

    depression in acute opiate toxicity.

    Perform CT scan and lumbar puncture & CSFculture to exclude traumatic, pathological or

    infectious coma.14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    46/62

    Hypothermia

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    47/62

    Treatment Maintain the airway and assist ventilation, and

    administer supplemental oxygen. Treatment of the cause (e.g. hypotension).

    I t e patient is not in car iac arrest, rewarm

    slowly using blankets, warm IV fluids, and

    warmed-O2 inhalation to prevent

    arrhythmias.

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    48/62

    Hyperthermia

    14/10/2011Prof Dr Ashraf M. Emara

    Hyperthermia

  • 8/3/2019 Today3 [Compatibility Mode]

    49/62

    Hyperthermia

    Malignant hyperthermia (inherited disorder)

    causes Severe hyperthermia

    Rigidity

    After exposure to certain anesthetic agents (e.g.

    halothane and succinylcholine).

    14/10/2011Prof Dr Ashraf M. Emara

    Hyperthermia

  • 8/3/2019 Today3 [Compatibility Mode]

    50/62

    Hyperthermia

    Treatment:

    A & B.

    Treatment of the cause (e.g. seizures).

    Shivering can be avoided by diazepam.

    Cooling (external & internal core). Neuromuscular paralysis (using

    nondepolarizing agent) together with,

    endotracheal intubation and mechanical

    ventilation is useful for severe cases.

    14/10/2011Prof Dr Ashraf M. Emara

    Hyperthermia

  • 8/3/2019 Today3 [Compatibility Mode]

    51/62

    Hyperthermia

    Treatment:

    Specific drugs:

    Bromocriptine in neuroleptic malignant syndrome

    14/10/2011Prof Dr Ashraf M. Emara

    Rhabdomyolysis

  • 8/3/2019 Today3 [Compatibility Mode]

    52/62

    Rhabdomyolysis

    Causes:

    Prolonged immobilization on a hard surface

    Excessive seizures

    Hyperthermia

    Direct cytotoxic effects (e.g. carbon monoxideand some snake venoms).

    14/10/2011Prof Dr Ashraf M. Emara

    Rhabdomyolysis

  • 8/3/2019 Today3 [Compatibility Mode]

    53/62

    Rhabdomyolysis

    Muscle tenderness

    Pigmenturia with urine that is orthotoluidine

    (Hematest) positive with few or no intact redblood cells.

    Renal failure Elevated serum creatine phosphokinase (CPK)

    level.

    14/10/2011Prof Dr Ashraf M. Emara

    Rhabdomyolysis

  • 8/3/2019 Today3 [Compatibility Mode]

    54/62

    Rhabdomyolysis

    Treatment:

    Maintain urine flow rate (35 mL/kg/h) with

    intravenous fluids. If oliguria occurred, consider a bolus of

    mannitol.

    Alkalinize the urine by sodium bicarbonate

    (acidic urine promotes deposition of myoglobin

    in the tubules). Hemodialysis may be needed, for acute renal

    failure.14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    55/62

    Poison Prevention Strategies

    Keep all house hold poisons separate from

    food. Keep all products in their original container.

    A ways rea a a e s care u y e ore using

    the product.

    Never take or give any medication in the dark.

    Dispose all toxic and medicinal products in asafe and proper manner.

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    56/62

    14/10/2011Prof Dr Ashraf M. Emara

    P i P i S i

  • 8/3/2019 Today3 [Compatibility Mode]

    57/62

    Poison Prevention Strategies

    Encourage periodic home hunts and dispose

    of old medication. Never refer to medicine or vitamins as candy.

    Teac c i ren never to ta e me ication

    unless given by adult they know.

    Once a child has been poisoned. Be alert for

    repeated episodes. Teach children not eat plants.

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    58/62

    14/10/2011Prof Dr Ashraf M. Emara

    P i P ti St t i

  • 8/3/2019 Today3 [Compatibility Mode]

    59/62

    Poison Prevention Strategies

    Keep all drugs or toxic substances out of

    children sight & reach; use cabinet locks.

    Keep the poison control center number at

    each telephone. Tanta university hospitals, Emergency

    Hospital.

    Emergency line : 0185103132Administrative line : 3350373

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    60/62

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    61/62

    14/10/2011Prof Dr Ashraf M. Emara

  • 8/3/2019 Today3 [Compatibility Mode]

    62/62

    14/10/2011Prof Dr Ashraf M. Emara